Merz Aesthetics UK and Ireland
Nishil Lakhani has extensive experience in quality assurance, currently serving as a Quality Assurance Associate at Merz Aesthetics UK and Ireland since December 2024. Prior roles include Senior Quality Assurance Specialist at IntuVigilance Limited from November 2021 to December 2024, where responsibilities included line management, leading audits, and managing internal quality systems. Previous positions also encompass roles as Quality Assurance Executive and Officer at Strides Pharma Inc., and Laboratory Technician and Compounder at various pharmaceutical and laboratory settings. Nishil holds a Bachelor's degree in Biomedical Sciences from De Montfort University, obtained in 2018.
This person is not in the org chart
This person is not in any teams
Merz Aesthetics UK and Ireland
At Merz Aesthetics UK and Ireland, we are known for our scientifically backed and category-leading medical devices, as well as our unique connections with customers. With our portfolio of minimally invasive aesthetics treatments, we are here to shape the future of healthcare practitioners’ practices whilst keeping medicine at the heart of everything we do. Our healthcare heritage began over 110 years ago, and we are proud our organisation is still owned by the same family. Because of this, we are able to put purpose before profit, so we are always ensuring we’re doing what’s right for our customers. Improving patient outcomes is a high priority for us- therefore we are eager to provide a world of learning to aesthetic healthcare practitioners through our educational platforms, ECADEMY and EVENTS, as well as face to face training led by experts in aesthetic medicine. Headquartered in Raleigh, NC, USA, Merz Aesthetics has approximately 1,500 employees in 32 countries worldwide. Merz Aesthetics is part of Merz Group, which has been family-owned since 1908. The official LinkedIn account for Merz Aesthetics UK and Ireland. Privacy notice - https://merz-aesthetics.co.uk/privacy-notice/ Our LinkedIn page operates under the LinkedIn terms of service (https://www.linkedin.com/legal/user-agreement) Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Reporting forms and information for Republic of Ireland can be found at https://www.hpra.ie/homepage/about-us/report-an-issue/mdiur. Adverse events should also be reported to Merz Pharma UK Ltd by email to UKdrugsafety@merz.com or on +44 (0) 333 200 4143.